Clinical Trial Update: MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for MBM-02 (Tempol) investigating treatment for glioblastoma/ glioblastoma multiforme is listed as status UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioblastoma Multiforme

Drugs mentioned

• MBM-02 (Tempol)

Snippet

Sponsor: Matrix Biomed, Inc. | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 2 | Status: UNKNOWN